UROGEN PHARMA LTD (URGN:NASDAQ)
$43.62 -1.88 (-4.1319%)
Analysed UROGEN PHARMA LTD (URGN:NASDAQ) News Sources
Why Did CVS, URGN, CCK Stocks Hit 52-Week Highs Today?
22-07-2026
stocktwits.com
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
29-07-2026
yahoo.com
Urogen Pharma (URGN) Reports Q2 Loss, Tops Revenue Estimates
05-08-2026
yahoo.com
Urogen Pharma Q2 Earnings Call Highlights
05-08-2026
marketbeat.com
UroGen Pharma Ltd (URGN) (Q2 2026) Earnings Call Highlights: Cysview Revenue Surges 73% as Net ...
05-08-2026
yahoo.com
Why UroGen Pharma (URGN) Is Up 22.8% After Q2 2026 Revenue Nearly Tripled And Losses Narrowed
09-08-2026
yahoo.com
UroGen (URGN) Q2 2026 Earnings Call Transcript
12-08-2026
fool.com
UroGen Announces Strategic Collaboration and Investment Agreements with IntraGel to Access Biodegradable Sustained-Release Gel Platform and Expand Oncology Pipeline
20-08-2026
yahoo.com
IntraGel Therapeutics and UroGen Pharma Sign Strategic Collaboration and Investment Agreements to Advance Sustained-Released Investigational Oncology Therapies
20-08-2026
yahoo.com
Wall Street Analysts Think Urogen Pharma (URGN) Could Surge 27.14%: Read This Before Placing a Bet
21-08-2026
yahoo.com
What is the current price of UROGEN PHARMA LTD (URGN:NASDAQ)?
The current price of UROGEN PHARMA LTD (URGN:NASDAQ) is $43.62.
UROGEN PHARMA LTD (URGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of UROGEN PHARMA LTD (URGN:NASDAQ) since the previous trading day is $-1.88.
UROGEN PHARMA LTD (URGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of UROGEN PHARMA LTD (URGN:NASDAQ) since the previous trading day is -4.1319%.
What is the most recent average sentiment score for UROGEN PHARMA LTD (URGN:NASDAQ)?
The most recent average sentiment score for UROGEN PHARMA LTD (URGN:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for UROGEN PHARMA LTD (URGN:NASDAQ)?
The most recent sentiment for UROGEN PHARMA LTD (URGN:NASDAQ) is .
SEC-8K** Filing Available For UROGEN PHARMA LTD (URGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.